Follow-up to management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis

Can Commun Dis Rep. 1998 Aug 15;24(16):129-32.
[Article in English, French]
No abstract available

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Anti-Bacterial Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Drug Interactions
  • HIV Protease Inhibitors / adverse effects*
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • Humans
  • Patient Selection
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Rifamycins / adverse effects*
  • Tuberculosis / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Rifamycins
  • HIV Reverse Transcriptase